Oryzon Genomics Bilan de santé
Santé financière contrôle des critères 3/6
Oryzon Genomics has a total shareholder equity of $92.7M and total debt of $19.3M, which brings its debt-to-equity ratio to 20.8%. Its total assets and total liabilities are $118.6M and $25.9M respectively.
Informations clés
20.8%
Ratio d'endettement
US$19.27m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$10.79m |
| Fonds propres | US$92.68m |
| Total du passif | US$25.88m |
| Total des actifs | US$118.56m |
Mises à jour récentes de la santé financière
Is Oryzon Genomics (BME:ORY) Using Too Much Debt?
Apr 04
Is Oryzon Genomics (BME:ORY) Weighed On By Its Debt Load?
May 01Oryzon Genomics (BME:ORY) Has Debt But No Earnings; Should You Worry?
Feb 26Recent updates
Growth Investors: Industry Analysts Just Upgraded Their Oryzon Genomics S.A. (BME:ORY) Revenue Forecasts By 54%
Oct 03Oryzon Genomics S.A. (BME:ORY) Screens Well But There Might Be A Catch
Jun 09Is Oryzon Genomics (BME:ORY) Using Too Much Debt?
Apr 04Industry Analysts Just Made A Dazzling Upgrade To Their Oryzon Genomics S.A. (BME:ORY) Revenue Forecasts
Jul 24Is Oryzon Genomics (BME:ORY) Weighed On By Its Debt Load?
May 01Oryzon Genomics (BME:ORY) Has Debt But No Earnings; Should You Worry?
Feb 26If You Had Bought Oryzon Genomics (BME:ORY) Shares A Year Ago You'd Have Earned 18% Returns
Jan 04
Analyse de la situation financière
Passif à court terme: ORY's short term assets ($14.9M) do not cover its short term liabilities ($15.7M).
Passif à long terme: ORY's short term assets ($14.9M) exceed its long term liabilities ($10.2M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: ORY's net debt to equity ratio (9.1%) is considered satisfactory.
Réduire la dette: ORY's debt to equity ratio has reduced from 33% to 20.8% over the past 5 years.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: ORY has less than a year of cash runway based on its current free cash flow.
Prévisions de trésorerie: ORY has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.8% each year